Improvement of endothelial function by pitavastatin: a meta-analysis.
Author | |
---|---|
Abstract | :
Dyslipidemia is commonly associated with endothelial dysfunction and increased cardiovascular risk. Pitavastatin has been shown to reduce total and low-density lipoprotein cholesterol, to increase high-density lipoprotein (HDL)-cholesterol and improve HDL function. Furthermore, several trials explored its effects on flow-mediated dilation (FMD), as an index of endothelial function. The authors evaluated the effect of pitavastatin therapy on FMD. |
Year of Publication | :
2018
|
Journal | :
Expert opinion on pharmacotherapy
|
Date Published | :
2018
|
ISSN Number | :
1465-6566
|
URL | :
http://www.tandfonline.com/doi/full/10.1080/14656566.2018.1428560
|
DOI | :
10.1080/14656566.2018.1428560
|
Short Title | :
Expert Opin Pharmacother
|
Download citation |